InsiderTrades

Form 4 for ODTX Odyssey Therapeutics, Inc.

Accepted 2026-05-11 20:30:26 ET · period of report 2026-05-11 · accession 0001193125-26-217593 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DI 2026-05-11 20:30 2026-05-11 ODTX Li Nan (LN) Dir C - Cnv Deriv — +1.71M 2.22M +333% —
DI 2026-05-11 20:30 2026-05-11 ODTX Li Nan (LN) Dir P - Purchase $18.00 +1.11M 3.33M +50% +$20.00M
DI 2026-05-11 20:30 2026-05-11 ODTX Li Nan (LN) Dir C - Cnv Deriv — -16.61M 0 -100% —

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-05-11 C A 1,709,543 — 2,222,405 I See footnote — — (F1) The Series D Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration. (F2) These securities are held by Dimension Capital II, L.P. Dimension Capital II, L.P. is controlled by Dimension Capital II GP, L.P., its general partner, which is itself controlled by Dimension Capital II GP, LLC. The Reporting Person, Adam Goulburn and Zavain Dar serve as the members of Dimension Capital II GP, LLC. The Reporting Person disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his indirect pecuniary interest therein.
2 Common Common Stock 2026-05-11 P A 1,111,111 $18.00 3,333,516 I See footnote — — (F3) Reflects shares purchased in the Issuer's initial public offering. (F2) These securities are held by Dimension Capital II, L.P. Dimension Capital II, L.P. is controlled by Dimension Capital II GP, L.P., its general partner, which is itself controlled by Dimension Capital II GP, LLC. The Reporting Person, Adam Goulburn and Zavain Dar serve as the members of Dimension Capital II GP, LLC. The Reporting Person disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his indirect pecuniary interest therein.
3 Derivative Series D Convertible Preferred Stock 2026-05-11 C D 16,611,626 — 0 I See footnote — · — to — 1,709,543 Common Stock (F1) The Series D Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration. (F1) The Series D Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration. (F1) The Series D Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration. (F1) The Series D Preferred Stock automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration. (F4) Gives effect to the 1-for-9.7170 reverse stock split effected prior to the closing of the Issuer's initial public offering. (F2) These securities are held by Dimension Capital II, L.P. Dimension Capital II, L.P. is controlled by Dimension Capital II GP, L.P., its general partner, which is itself controlled by Dimension Capital II GP, LLC. The Reporting Person, Adam Goulburn and Zavain Dar serve as the members of Dimension Capital II GP, LLC. The Reporting Person disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his indirect pecuniary interest therein.